Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation

被引:97
作者
Wells, AD
Rai, SK
Salvato, MS
Band, H
Malkovsky, M
机构
[1] Univ Wisconsin, Sch Med, Bardeen Med Labs, Dept Med Microbiol & Immunol, Madison, WI 53706 USA
[2] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53706 USA
[3] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA
[4] Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53706 USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Rheumatol & Immunol, Boston, MA 02115 USA
关键词
major histocompatibility antigens; molecular chaperone; T lymphocytes; tumor immunogenicity;
D O I
10.1093/intimm/10.5.609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Efficient recognition of tumor cells by cytolytic T lymphocytes (CTL) is often dependent on the presentation of cytosolic peptides in the context of MHC class I molecules. This process may be influenced by various molecular chaperones. To analyze this influence, we have utilized B16 melanoma cells, which are not effectively recognized by MHC class I-restricted CTL. This resistance to CTL is apparently due to a very low level of surface MHC expression. We have found that stably transfected clones of B16 which constitutively express the human heat shock protein 72 (Hsp72) exhibit significantly increased levels of MHC class I antigens on their surface. This Hsp72-mediated up-regulation of surface MHC class I antigen represents an increase in the amount of functional WHC-peptide complexes as measured by conformation-dependent antibodies and recognition by MHC class I-restricted CTL. Expression of Hsp72 did not improve the antigen presentation defect in cells lacking the activity of the transporter associated with antigen presentation (TAP). Moreover, mice immunized with Hsp72-expressing B16 cells, but not with control-transfected B16 cells, display significantly increased resistance to a subsequent challenge with live, wild-type B16. Together, our data demonstrate that the immune recognition of tumor cells can be substantially enhanced by the suitable expression of a molecular chaperone.
引用
收藏
页码:609 / 617
页数:9
相关论文
共 40 条
[1]   DOMAIN INTERACTIONS OF H-2 CLASS-I ANTIGENS ALTER CYTO-TOXIC T-CELL RECOGNITION SITES [J].
ALLEN, H ;
WRAITH, D ;
PALA, P ;
ASKONAS, B ;
FLAVELL, RA .
NATURE, 1984, 309 (5965) :279-281
[2]   PEPTIDE-INDUCED STABILIZATION AND INTRACELLULAR-LOCALIZATION OF EMPTY HLA CLASS-I COMPLEXES [J].
BAAS, EJ ;
VANSANTEN, HM ;
KLEIJMEER, MJ ;
GEUZE, HJ ;
PETERS, PJ ;
PLOEGH, HL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :147-156
[3]  
BUKOWSKI JF, 1995, J IMMUNOL, V154, P998
[4]  
CRISTAU B, 1994, J IMMUNOL, V152, P1546
[5]  
Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X
[6]  
GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cellbio.9.1.601
[7]   MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION [J].
GERMAIN, RN .
CELL, 1994, 76 (02) :287-299
[8]   CONSERVED FEATURES OF EUKARYOTIC HSP70 GENES REVEALED BY COMPARISON WITH THE NUCLEOTIDE-SEQUENCE OF HUMAN HSP70 [J].
HUNT, C ;
MORIMOTO, RI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) :6455-6459
[9]  
KAKLAMANIS L, 1995, CANCER RES, V55, P5191
[10]  
KIM TS, 1994, CANCER IMMUNOL IMMUN, V38, P185